Biotricity, Inc. (BTCY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Redwood City, CA, United States. Der aktuelle CEO ist Waqaas Al-Siddiq.
BTCY hat IPO-Datum 2018-02-16, 55 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $7.68M.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
